X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14538) 14538
Book Review (2947) 2947
Publication (705) 705
Book Chapter (177) 177
Conference Proceeding (76) 76
Magazine Article (11) 11
Dissertation (4) 4
Book / eBook (3) 3
Web Resource (3) 3
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10423) 10423
anticoagulation (10324) 10324
humans (9764) 9764
female (5661) 5661
male (5608) 5608
aged (4436) 4436
warfarin (4217) 4217
middle aged (4046) 4046
anticoagulants - therapeutic use (3769) 3769
atrial fibrillation (3444) 3444
anticoagulants (3373) 3373
cardiac & cardiovascular systems (3222) 3222
stroke (2731) 2731
risk factors (2726) 2726
anticoagulants - administration & dosage (2357) 2357
therapy (2330) 2330
anticoagulants - adverse effects (2321) 2321
adult (2224) 2224
peripheral vascular disease (2152) 2152
treatment outcome (2105) 2105
hematology (2073) 2073
management (2040) 2040
aged, 80 and over (2028) 2028
oral anticoagulation (1962) 1962
thromboembolism (1779) 1779
thrombosis (1769) 1769
risk (1763) 1763
retrospective studies (1748) 1748
abridged index medicus (1579) 1579
prevention (1576) 1576
surgery (1475) 1475
atrial fibrillation - drug therapy (1448) 1448
warfarin - therapeutic use (1420) 1420
international normalized ratio (1325) 1325
atrial fibrillation - complications (1310) 1310
medicine, general & internal (1308) 1308
stroke - prevention & control (1260) 1260
heparin (1237) 1237
medicine & public health (1202) 1202
care and treatment (1186) 1186
atrial-fibrillation (1139) 1139
venous thromboembolism (1127) 1127
aspirin (1125) 1125
hemorrhage - chemically induced (1119) 1119
pharmacology & pharmacy (1114) 1114
prospective studies (1067) 1067
mortality (1041) 1041
warfarin - adverse effects (1040) 1040
warfarin - administration & dosage (1020) 1020
analysis (1011) 1011
antithrombotic therapy (1010) 1010
time factors (1008) 1008
cardiology (994) 994
administration, oral (982) 982
risk-factors (919) 919
bleeding (903) 903
complications (886) 886
stroke - etiology (886) 886
risk assessment (879) 879
stroke prevention (870) 870
drug therapy (869) 869
hemorrhage (860) 860
follow-up studies (857) 857
molecular-weight heparin (851) 851
dabigatran (809) 809
patients (805) 805
clinical neurology (804) 804
health aspects (748) 748
thromboembolism - prevention & control (743) 743
cardiac arrhythmia (722) 722
incidence (695) 695
prevalence (662) 662
anticoagulation therapy (659) 659
guidelines (650) 650
blood coagulation - drug effects (642) 642
adolescent (635) 635
cardiovascular (627) 627
internal medicine (627) 627
outcomes (619) 619
research (610) 610
safety (608) 608
dosage and administration (595) 595
platelet aggregation inhibitors - therapeutic use (584) 584
fibrinolytic agents - therapeutic use (579) 579
cohort studies (577) 577
metaanalysis (567) 567
trial (562) 562
rivaroxaban (544) 544
pulmonary embolism (536) 536
antiplatelet therapy (531) 531
urology & nephrology (529) 529
atrial fibrillation - therapy (517) 517
diagnosis (516) 516
dose-response relationship, drug (511) 511
heparin - adverse effects (511) 511
complications and side effects (504) 504
heparin - therapeutic use (504) 504
atrial fibrillation - epidemiology (497) 497
prognosis (497) 497
deep-vein thrombosis (487) 487
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13366) 13366
German (608) 608
French (306) 306
Spanish (225) 225
Japanese (68) 68
Russian (53) 53
Portuguese (38) 38
Polish (26) 26
Korean (22) 22
Czech (18) 18
Italian (9) 9
Turkish (8) 8
Hungarian (7) 7
Slovak (4) 4
Chinese (3) 3
Dutch (2) 2
Icelandic (2) 2
Georgian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis and Haemostasis, ISSN 0340-6245, 2015, Volume 113, Issue 6, pp. 1247 - 1257
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2008, Volume 51, Issue 8, pp. 818 - 825
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 05/2016, Volume 115, Issue 5, pp. 939 - 949
The effectiveness and safety of rivaroxaban for stroke prevention in atrial fibrillation (SPAF) demonstrated in ROCKET AF needs to be confirmed in daily care.... 
Persistence | Rivaroxaban | Anticoagulation | Atrial fibrillation | Bleeding | bleeding | MANAGEMENT | HEMORRHAGE | RISK | rivaroxaban | DISCONTINUATION | STROKE | RATES | atrial fibrillation | DABIGATRAN | WARFARIN | ORAL ANTICOAGULANTS | persistence | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 16, pp. 1513 - 1524
In this trial, dabigatran plus a P2Y 12 inhibitor was compared with warfarin plus a P2Y 12 inhibitor and aspirin after PCI in patients with atrial... 
MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | HEART-DISEASE | MYOCARDIAL-INFARCTION | ORAL ANTICOAGULATION | 2011 ACCF/AHA/SCAI GUIDELINE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | TRIPLE THERAPY | ANTIPLATELET THERAPY | CONSENSUS DOCUMENT | Dabigatran - adverse effects | Ticlopidine - therapeutic use | Humans | Middle Aged | Warfarin - adverse effects | Male | Risk | Dabigatran - therapeutic use | Incidence | Warfarin - therapeutic use | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Therapy, Combination - adverse effects | Adenosine - adverse effects | Adenosine - therapeutic use | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Purinergic P2Y Receptor Antagonists - therapeutic use | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Atrial Fibrillation - therapy | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention | Warfarin | Atrial fibrillation | Dosage and administration | Research | Thromboembolism | Hemorrhage | Health aspects | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Embolisms | Preventive medicine | Thrombosis | Bleeding | Embolism | Fibrillation | Cardiology | Drug therapy | Drug dosages | Geriatrics | Index Medicus | Abridged Index Medicus | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 09/2012, Volume 126, Issue 10, pp. 1185 - 1193
Background-Uncertainty remains over optimal antithrombotic treatment of patients with atrial fibrillation presenting with myocardial infarction and/or... 
atrial fibrillation | percutaneous coronary intervention | triple therapy | myocardial infarction | anticoagulants | antithrombotic treatment | hemorrhage | CARDIAC & CARDIOVASCULAR SYSTEMS | ORAL ANTICOAGULATION | HEART RHYTHM ASSOCIATION | RISK | EUROPEAN-SOCIETY | ASPIRIN | CONSENSUS DOCUMENT | STENT IMPLANTATION | DUAL ANTIPLATELET THERAPY | WARFARIN | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | CARDIOLOGY WORKING GROUP | Myocardial Infarction - mortality | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Hemorrhage - mortality | Male | Hemorrhage - prevention & control | Angioplasty, Balloon, Coronary | Aspirin - administration & dosage | Fibrinolytic Agents - adverse effects | Myocardial Infarction - therapy | Drug Therapy, Combination - adverse effects | Vitamin K - antagonists & inhibitors | Aspirin - adverse effects | Atrial Fibrillation - mortality | Registries - statistics & numerical data | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Aged, 80 and over | Ticlopidine - administration & dosage | Female | Stroke - mortality | Platelet Aggregation Inhibitors - adverse effects | Atrial Fibrillation - drug therapy | Comorbidity | Risk Factors | Ticlopidine - analogs & derivatives | Acute Coronary Syndrome - drug therapy | Denmark - epidemiology | Aged | Fibrinolytic Agents - administration & dosage | Hemorrhage - chemically induced | Cohort Studies | Usage | Thrombolytic drugs | Research | Hemorrhage | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Stroke, ISSN 0039-2499, 11/2013, Volume 44, Issue 11, pp. 3103 - 3108
Journal Article
Circulation, ISSN 0009-7322, 02/2007, Volume 115, Issue 6, pp. 813 - 818
Journal Article
Journal Article